skip to content

Pharmacovigilance

Pharmacovigilance Workshop

Sujung Lee 

  • Sujung LeeDirector,
    Pharmaceutical Safety Evaluation Division,
    MFDS
    • ▶ Opening Ceremony
      • Keynote Speech
    • ▶ Session I (Chair)
    • ▶ Wrap up
      • Wrap up and Conclusion

Linda Harmark 

  • Linda HarmarkHead,
    Innovation and projects,
    Netherlands Pharmacovigilance Centre Lareb
    • ▶ Session I
      • Pharmacovigilance Activities of EU (Regulatory perspective)
    • ▶ Session II (Panelist)
    • ▶ Session III (Chair)

Cesar Luis Avalos Capristan 

  • Cesar Luis Avalos CapristanPharmacovigilance Team Member,
    Direction of Access and Use of Medicines,
    DIGEMID
    • ▶ Session I
      • Pharmacovigilance Activities of Asia-Pacific (Regulatory perspective)
    • ▶ Session III (Panelist)

Lanette Lee A. Querubin 

  • Lanette Lee A. QuerubinOfficer-in Charge,
    Product Research and Standards Development Division,
    Center for Drug Regulation and Research,
    FDA Philippines
    • ▶ Session I
      • Pharmacovigilance Activities of Asia-Pacific (Regulatory perspective)
    • ▶ Session II (Panelist)

Yong-soo Kim 

  • Yong-soo KimChief Scientific Officer,
    CD & MA,
    Novartis Korea
    • ▶ Session I
      • Pharmacovigilance Activities of Industry
    • ▶ Session II (Panelist)
    • ▶ Session III (Panelist)

Kazuhiko Ishida 

  • Kazuhiko IshidaAssociate Risk Management Director
    Pharmacovigilance,
    JPMA
    • ▶ Session I
      • Pharmacovigilance Activities of Industry
    • ▶ Session III (Panelist)

Gerald Dal Pan 

  • Gerald Dal PanDirector,
    Office of Surveillance and Epidemiology,
    U.S. FDA
    • ▶ Session II (Chair, Panelist)
    • ▶ Session III (Panelist)
      • Effective methods for Risk-Benefit evaluation

Anki Hagstrom 

  • Anki HagstromHead,
    Global Services,
    UMC
    • ▶ Session II (Panelist)
      • Effective methods for Risk-Benefic evaluation

Nafiza Mohd Ismail 

  • Nafiza Mohd IsmailPrincipal Assistant Director,
    Centre for Post-Registration for Product,
    National Pharmaceutical Regulatory Agency,
    MoH Malaysia
    • ▶ Session II (Panelist)

Siti Asfijah Abdoellah 

  • Siti Asfijah AbdoellahHead,
    Directorate of Distribution Control of Therapeutic,
    NADFC
    • ▶ Session II (Panelist)

Yaowares Oppamayun 

  • Yaowares OppamayunAssistant Head,
    Health Product Vigilance Center, Technical and Planning
    Division,
    Thai FDA
    • ▶ Session II (Panelist)

Daisuke Tanaka 

  • Daisuke TanakaTechnical Officer,
    Safety & Vigilance: Medicines, Essential Medicines and Health Product,
    WHO
    • ▶ Session III (Panelist)